Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion
Enrique G Cifuentes, Mary G Hornick, Suresh Havalad, Ramona L Donovan, Anil Gulati, Enrique G Cifuentes, Mary G Hornick, Suresh Havalad, Ramona L Donovan, Anil Gulati
Abstract
Objective: The purpose of this study was to determine the potential neuroprotective effect of endothelin B (ETB) receptor agonist IRL-1620 treatment in a pediatric model of ischemic stroke. Design: A prospective, animal model study. Setting: An experimental laboratory. Subjects: Three-month-old male Wistar Han rats. Interventions: The rats underwent permanent middle cerebral artery occlusion (MCAO). At 2, 4, and 6 h post MCAO, they were treated with saline, IRL-1620 (5 μg/kg, IV), and/or ETB antagonist BQ788 (1 mg/kg, IV). Measurements and Main Results: The rats were evaluated over the course of 7 days for neurological and motor deficit, cerebral blood flow (CBF), and infarct volume. Young rats treated with IRL-1620 following MCAO improved significantly in neurological and motor assessments as compared to the vehicle-treated group, as measured by neurological score (P = 0.00188), grip test (P < 0.0001), and foot-fault error (P = 0.0075). CBF in the infarcted hemisphere decreased by 45-50% in all groups immediately following MCAO. After 7 days, CBF in the infarcted hemisphere of the IRL-1620 group increased significantly (P = 0.0007) when compared to the vehicle-treated group (+2.3 ± 23.3 vs. -45.4 ± 10.2%). Additionally, infarct volume was significantly reduced in IRL-1620-treated rats as compared to vehicle-treated rats (P = 0.0035, 41.4 ± 35.4 vs. 115.4 ± 40.9 mm3). Treatment with BQ788 blocked the effects of IRL-1620. Conclusions: IRL-1620 significantly reduced neurological and motor deficit as well as infarct volume while increasing CBF in a pediatric rat model of cerebral ischemia. These results indicate that selective ETB receptor stimulation may provide a novel therapeutic strategy in the treatment of pediatric ischemic stroke as has been demonstrated in adult ischemic stroke.
Keywords: cerebral blood flow; cerebral infarction; endothelin B receptor agonists; ischemic penumbra; reperfusion; stroke.
Figures
References
- Tsze DS, Valente JH. Pediatric stroke: a review. Emerg Med Int. (2011) 2011:734506. 10.1155/2011/734506
- Titomanlio L, Zanin A, Sachs P, Khaled J, Elmaleh M, Blanc R, et al. . Pediatric ischemic stroke: acute management and areas of research. J Pediatr. (2013) 162:227.e1–35.e1. 10.1016/j.jpeds.2012.09.018
- Numis AL, Fox CK. Arterial ischemic stroke in children: risk factors and etiologies. Curr Neurol Neurosci Rep. (2014) 14:422. 10.1007/s11910-013-0422-8
- Pezzati M, Filippi L, Chiti G, Dani C, Rossi S, Bertini G, et al. . Central venous catheters and cardiac tamponade in preterm infants. Intensive Care Med. (2004) 30:2253–6. 10.1007/s00134-004-2472-5
- Sol JJ, van de Loo M, Boerma M4, Bergman KA, Donker AE, van der Hoeven MAHBM, et al. . NEOnatal central-venous line observational study on thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related thrombosis. BMC Pediatr. (2018) 18:84. 10.1186/s12887-018-1000-7
- Takahashi K, Ghatei MA, Jones PM, Murphy JK, Lam HC, O'Halloran DJ, et al. . Endothelin in human brain and pituitary gland: comparison with rat. J Cardiovasc Pharmacol. (1991) 17(Suppl. 7):S101–3. 10.1097/00005344-199100177-00026
- Rogers SD, Demaster E, Catton M, Ghilardi JR, Levin LA, Maggio JE, et al. . Expression of endothelin-B receptors by glia in vivo is increased after CNS injury in rats, rabbits, and humans. Exp Neurol. (1997) 145:180–95. 10.1006/exnr.1997.6468
- Schinelli S. Pharmacology and physiopathology of the brain endothelin system: an overview. Curr Med Chem. (2006) 13:627–38. 10.2174/092986706776055652
- Koyama Y, Michinaga S. Regulations of astrocytic functions by endothelins: roles in the pathophysiological responses of damaged brains. J Pharmacol Sci. (2012) 118:401–7. 10.1254/jphs.11R13CP
- Morton AJ, Davenport AP. Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b. Brain Res. (1992) 581:299–306. 10.1016/0006-8993(92)90721-K
- Lucas GA, White LR, Juul R, Cappelen J, Aasly J, Edvinsson L. Relaxation of human temporal artery by endothelin ETB receptors. Peptides (1996) 17:1139–44. 10.1016/S0196-9781(96)00177-5
- Leonard MG, Briyal S, Gulati A. Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats. Brain Res. (2011) 1420:48–58. 10.1016/j.brainres.2011.08.075
- Leonard MG, Briyal S, Gulati A. Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats. Brain Res. (2012) 1464:14–23. 10.1016/j.brainres.2012.05.005
- Leonard MG, Gulati A. Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats. Brain Res. (2013) 1528:28–41. 10.1016/j.brainres.2013.07.002
- Gulati A, Hornick MG, Briyal S, Lavhale MS. A novel neuroregenerative approach using ET(B) receptor agonist, IRL-1620, to treat CNS disorders. Physiol Res. (2018) 67:S95–1123. Available online at:
- Sengupta P. The laboratory rat: relating its age with human's. Int J Prev Med. (2013) 4:624–30. Available online at:
- Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. I A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke (1986) 8:1–8. 10.3995/jstroke.8.1
- Tatlisumak T, Carano RA, Takano K, Opgenorth TJ, Sotak CH, Fisher M. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. Stroke (1998) 29:850–7; discussion: 857–8. 10.1161/01.STR.29.4.850
- Moran PM, Higgins LS, Cordell B, Moser PC. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci USA. (1995) 92:5341–5. 10.1073/pnas.92.12.5341
- Markgraf CG, Green EJ, Hurwitz BE, Morikawa E, Dietrich WD, McCabe PM, et al. . Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. (1992) 575:238–246. 10.1016/0006-8993(92)90085-N
- Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke (1997) 28:2060–65; discussion: 2066. 10.1161/01.STR.28.10.2060
- Barone FC, White RF, Elliott JD, Feuerstein GZ, Ohlstein EH. The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury. J Cardiovasc Pharmacol. (1995) 26(Suppl. 3):S404–7. 10.1097/00005344-199506263-00119
- Ehrenreich H, Nau TR, Dembowski C, Hasselblatt M, Barth M, Hahn A, et al. . Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience (2000) 95:993–1001. 10.1016/S0306-4522(99)00507-2
- Vidovic M, Chen MM, Lu QY, Kalloniatis KF, Martin BM, Tan AH, et al. . Deficiency in endothelin receptor B reduces proliferation of neuronal progenitors and increases apoptosis in postnatal rat cerebellum. Cell Mol Neurobiol. (2008) 28:1129–38. 10.1007/s10571-008-9292-z
- Leonard MG, Prazad P, Puppala B, Gulati A. Selective endothelin-B receptor stimulation increases vascular endothelial growth factor in the rat brain during postnatal development. Drug Res. (2015) 65:607–13. 10.1055/s-0034-1398688
- Briyal S, Nguyen C, Leonard M, Gulati A. Stimulation of endothelin B receptors by IRL-1620 decreases the progression of Alzheimer's disease. Neuroscience (2015) 301:1–11. 10.1016/j.neuroscience.2015.05.044
- Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Konno S, Takeda H. Dilatation of cerebral microvessels mediated by endothelin ETB receptor and nitric oxide in cats. Neurosci Lett. (1994) 176:157–60. 10.1016/0304-3940(94)90071-X
- Kitazono T, Heistad DD, Faraci FM. Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats. Hypertension (1995) 25:490–4. 10.1161/01.HYP.25.4.490
- Leonard MG, Gulati A. Repeated administration of ET(B) receptor agonist, IRL-1620, produces tachyphylaxis only to its hypotensive effect. Pharmacol Res. (2009) 60:402–10. 10.1016/j.phrs.2009.07.015
- Rivkin MJ, Bernard TJ, Dowling MM, Amlie-Lefond C. Guidelines for urgent management of stroke in children. Pediatr Neurol. (2016) 56:8–17. 10.1016/j.pediatrneurol.2016.01.016
Source: PubMed